http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a48b3a79ab00f9bdc8d3880aa2b5573d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | de Jonge Jonge |
| name | Evert de Jonge |
| given-name | Evert de Evert |
| organization-name | Leiden University Medical CenterLeiden, the Netherlands Department of Intensive Care, Leiden University Medical Centre, Leiden, The Netherlands. Department of Intensive Care Medicine,3 University of Amsterdam, Amsterdam, The Netherlands From the Laboratory of Experimental Internal Medicine, the Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, the Department of Human Retrovirology, the Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators Department of Intensive Care Medicine Leiden University Medical Center Leiden the Netherlands All authors: Department of Intensive Care, Leiden University Medical Centre, Leiden, The Netherlands. Department of Intensive Care Medicine, Leiden University Medical Centre, Leiden, The Netherlands Department of Intensive Care Medicine Leiden University Medical Center Leiden The Netherlands. National Intensive Care Evaluation (NICE) foundation, Amsterdam, The Netherlands. Department of Clinical Chemistry Erasmus University Medical Center 's‐Gravendijkwal 230 3015CE Rotterdam the Netherlands REMAP-CAP Writing Committee for the REMAP-CAP Investigators Department of Intensive Care Medicine, Leiden University Medical Center, Leiden Intensive Care, Amsterdam, The Netherlands Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands Writing Committee for the REMAP-CAP Investigators Department of Intensive Care Medicine, Leiden University Medical Centre, Leiden, The Netherlands. Department of Intensive Care, Leiden University Medical Center , Leiden , The Netherlands From the Laboratory for Experimental Internal Medicine and Department of Intensive Care, Academic Medical Center, University of Amsterdam, and Organon Teknika, Boxtel, The Netherlands. Departments of Intensive Care; Internal Medicine; Laboratory of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands; Corvas International, San Diego, California Department of Intensive Care Medicine, University Medical Center Leiden, Leiden, The Netherlands. Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam 5Department of Clinical Chemistry, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands Department of Intensive Care Medicine, Leiden University Medical Center, Leiden, The Netherlands From the Department of Intensive Care, Laboratory of Experimental Internal Medicine, and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Central Laboratory of the Red Cross Blood Transfusion Service, Amsterdam, The Netherlands; Searle Research & Development, Skokie, IL; and Chiron Corporation, Emeryville, CA. Department of Intensive Care Medicine, Leiden University Medical Center, Leiden, The Netherlands. Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands. Department of Intensive Care, Leiden University Medical Centre, Leiden, the Netherlands Erasmus MC Rotterdam, Rotterdam, the Netherlands Department of Clinical Chemistry Erasmus University Medical Center Rotterdam The Netherlands Department of Intensive Care Leiden University Medical Center Leiden The Netherlands Department of Intensive Care, Leiden University Medical Center, Leiden, the Netherlands |
Incoming Links
Total number of triples: 229.